Search

everythinglearnresearchcommunity

for

Search:↓

A woman with severe hair loss due to systemic sclerosis regrew her hair in 4 months using a combination of treatments.

Some blood-thinning medications can increase the risk of bleeding, and certain factors like genetics and other health conditions affect their safety and effectiveness.

Thyroid disease can cause hair loss and treating thyroid problems might help with hair disorders.

Melatonin directly affects mouse hair follicles and may influence hair growth.

COVID-19 leaves 80% of patients with long-term symptoms like fatigue and headaches.

Vitiligo is a skin condition causing white spots, more common in women, often starts before age 20, and can affect mental health.

Rosacea is a skin condition with unclear causes, classified into four subtypes.

Chemotherapy can cause various skin reactions, with hair loss being the most common, and proper diagnosis and treatment of these reactions are important.

Targeting androgen receptors could be a promising way to treat skin disorders with fewer side effects.

Liposomes could improve how skin care products work but are costly and not very stable.

Alopecia areata treatment varies, with no optimal method established yet.

Antioxidants may help fight oxidative stress linked to autoimmune skin diseases.

Nanotechnology in dermatology shows promise for better drug delivery and treatment effectiveness but requires more safety research.

The document explains different types of hair loss, their causes, and treatments, and suggests future research areas.

Hair follicles offer promising targets for delivering drugs to treat hair and skin conditions.

Targeted cancer therapies often cause skin problems that need careful management to improve patient quality of life and treatment success.

Using psychological treatments can help manage skin conditions along with regular medical care.

Some treatments work for common baldness, but there's less evidence for other hair loss types, and more research is needed.

Low vitamin D might be linked to certain types of hair loss, and supplements could help, but more research is needed.

Psychotropic medications can cause skin reactions, including severe conditions like SJS and TEN, and it's important for psychiatrists to recognize and manage these side effects.

Betacoronaviruses, like COVID-19, may cause hormone system dysfunction and affect disease susceptibility and severity.

New chemotherapy drugs cause skin side effects, but treatments like minocycline and tetracycline can help reduce them.

Some anticonvulsant drugs can cause skin reactions, ranging from mild to severe, and managing these reactions is important for patient care.

COVID-19 may harm male fertility and damage the reproductive system.

The new FDA labeling rules provide more detailed drug safety information for pregnant and breastfeeding women, but more data is needed on the risks of many dermatologic drugs.

Young female Australian fur seals are losing hair due to low tyrosine and zinc levels and high pollution exposure.

COVID-19 and hypopituitarism (reduced pituitary gland function) are linked, with the latter's related health issues potentially worsening COVID-19 outcomes, and COVID-19 possibly increasing risk for pituitary complications.

Proper skin toxicity management in chemotherapy is key to continuing treatment and keeping patient quality of life high.

Diabetes can lead to blindness and skin problems, and managing blood sugar and blood pressure is crucial to prevent these complications.

Nanotechnology is improving drug delivery and targeting, with promising applications in cancer treatment, gene therapy, and cosmetics, but challenges remain in ensuring precise delivery and safety.